Dr. Van Den Brink is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
City of Hope (Duarte)
1500 East Duarte Road
Duarte, CA 91010Phone+1 626-218-4328
Summary
- Dr. Marcel Van Den Brink is the President of City of Hope Los Angeles and National Medical Center
and Chief Physician Executive. He received his medical degree from Leiden University Faculty of Medicine and has been in practice 31 years. He specializes in hematologic oncology and is experienced in hematologic oncology.
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 1994 - 1999
Duke University HospitalResidency, Internal Medicine, 1991 - 1993
Leiden University Faculty of MedicineClass of 1986
Certifications & Licensure
NY State Medical License 2001 - 2024
MA State Medical License 1995 - 1999- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 3 citationsAuthor Correction: Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy.Melody Smith, Anqi Dai, Guido Ghilardi, Kimberly V Amelsberg, Sean M Devlin
Nature Medicine. 2023-11-01 - 18 citationsA phase 2 study of interleukin-22 and systemic corticosteroids as initial treatment for acute GVHD of the lower GI tract.Doris M Ponce, Amin M Alousi, Ryotaro Nakamura, John Slingerland, Marco Calafiore
Blood. 2023-03-23 - 10 citationsAmbient oxygen levels regulate intestinal dysbiosis and GVHD severity after allogeneic stem cell transplantation.Keisuke Seike, Anders Kiledal, Hideaki Fujiwara, Israel Henig, Marina Burgos da Silva
Immunity. 2023-02-14
Lectures
- Double-Unit Cord Blood (CB) Transplantation with Haplo-Identical CD34+ Cells (haplo-dCBT) May Speed Neutrophil Recovery Although Successful Bridging Is Contingent on C...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Expression of the Butyrate/Niacin Receptor, GPR109a on T Cells Plays an Important Role in a Mouse Model of Graft Versus Host Disease2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
